Skip to main content

Posterior Urethral Stenosis

Posterior urethral stenosis is narrowing of the urethra proximal to the corpus spongiosum: the bladder neck, prostatic urethra and membranous urethra, including the bulbomembranous junction. The SIU/ICUD consultation uses stricture for the anterior urethra, where scar involves the epithelium and corpus spongiosum (spongiofibrosis). It uses stenosis for the posterior urethra, which has no spongiosum.[1][2]

The distinction has practical consequences. Posterior scar lies against the bladder neck and external urethral sphincter, so every treatment weighs patency against continence. Evidence from anterior strictures, such as the case against repeated urethrotomy, does not transfer directly. After radical prostatectomy, for example, repeated endoscopic treatment of anastomotic stenosis is often justified.[3]

This page covers the shared framework for all posterior stenoses. It also has a full section on radiation-induced stenosis, which is mainly bulbomembranous. Radiation changes the management of every type of posterior stenosis. Radiation-specific management of anastomotic and bladder-neck stenosis is on the VUAS and BNC pages. For anterior disease, see Male Urethral Stricture.

At a Glance​

  • Name the entity first. Bladder neck contracture after benign outlet surgery, anastomotic stenosis after prostatectomy, radiation-induced stenosis, pelvic fracture injury and membranous stenosis after endoscopic prostate surgery differ in biology, sphincter risk and treatment.
  • Characterize before treating. Assess obliteration, length, proximal extent, bladder-neck competence, baseline continence, bladder function, prior radiation and fistula.[4][2]
  • Non-obliterative stenosis: endoscopic treatment first. Unlike anterior stricture, a repeat attempt is reasonable.[3][2]
  • Obliterative, radiated or recalcitrant stenosis: reconstruct or divert. Do not attempt blind endoscopy. Avoid deep incisions at 6 and 12 o'clock after radiation.[2]
  • Radiated bulbomembranous stenosis: excision and primary anastomosis (EPA) gives the most durable patency for a short segment (10-year recurrence 6.8% versus 20% after buccal onlay). A non-transecting dorsal onlay graft suits longer disease or a urethra that must be kept for an AUS.[5][6]
  • Patency first, continence second. Place an artificial urinary sphincter (AUS) only after the outlet is stable. Radiation and prior urethroplasty, especially transecting repair, raise AUS failure.[7][6]
  • Look early with a cystoscope. A lumen narrower than 17 Fr at the first postoperative urethroscopy strongly predicts later reintervention.[8]

The Entities​

EntityUsual causeLevelKey issueDetailed page
Bladder neck contracture (BNC)TURP, enucleation, vaporization, bladder-neck incisionNative bladder neckExternal sphincter usually spared; endoscopic treatment often durableBladder Neck Contracture
Vesicourethral anastomotic stenosis (VUAS)Radical prostatectomy, with or without radiationVesicourethral anastomosisRhabdosphincter immediately distal to the scarVesicourethral Anastomotic Stenosis
Radiation-induced stenosisEBRT, brachytherapy, combined treatment or radiation after prostatectomyUsually bulbomembranous; also bladder neck, prostatic urethra or anastomosisIschemic tissue, higher incontinence and AUS risk, possible fistula or necrosisSection below
Pelvic fracture urethral injury (PFUI)Pelvic fracture with urethral distractionMembranous urethraObliterative gap with a displaced prostate; delayed anastomotic repairPFUI
Membranous stenosis after endoscopic prostate surgeryTURP, laser or enucleation, without radiationMembranous or bulbomembranous urethraAfter outlet surgery the bladder neck is often incompetent, so continence depends on the sphincter segment that is scarredReconstruction below

Older series often grouped BNC and VUAS together, and many posterior reconstruction series mix several entities. Check the population before applying a result.

Incidence​

SettingEstimateSource and limits
BNC after transurethral prostate surgery1.3% after TURP, 0.66% after enucleation, 1.2% after ablationMeta-analysis of randomized trials; differences were not significant[9]
VUAS after radical prostatectomy851 of 17,904 men (4.8%), at median 3.4 monthsSingle-institution registry 1987–2013, excluding prior radiation. Robotic approach (OR 0.39) and complete nerve sparing (OR 0.63) were protective[10]
After prostate radiotherapySee Incidence and timing after radiationRises with follow-up and with combined-modality treatment

For PFUI incidence and classification, see PFUI.

Evaluation​

Common to all entities:[4][2]

  • Symptoms and function. Voiding and storage symptoms, retention or catheter dependence, infection, and patient-reported outcome measures.
  • Urethral rest. Avoid evaluating through an indwelling urethral catheter. One robotic reconstruction group places a suprapubic tube and allows about 4 weeks of rest before assessment.[11]
  • Uroflowmetry and post-void residual.
  • Cystoscopy. Many series define stenosis as failure to pass a 16–17 Fr cystoscope.[10][5] In a patient with a suprapubic tube, antegrade flexible cystoscopy through the tract shows the proximal side.
  • Retrograde urethrography with voiding cystourethrography. Defines location and length. If the proximal urethra does not fill, perform a combined antegrade and retrograde study.
  • MRI. For PFUI planning, and for suspected fistula, osteomyelitis or prostatic cavitation.
  • Bladder-neck competence and baseline continence. Assess on cystogram or antegrade cystoscopy. These predict continence after the outlet is opened.
  • Urodynamics when storage dysfunction or incontinence would change the plan. Renal function and PSA in cancer survivors.

Management Framework​

ScenarioUsual approachNotes
Non-obliterative, first presentationDilation, incision or resectionNo head-to-head trials. Warn that relieving obstruction can reveal stress incontinence[2]
Recurrence after endoscopyA further endoscopic attempt is reasonable; escalate after repeated failureFor VUAS, one treatment succeeded in 44.2%, but 91% were patent after a mean of 2.1 treatments. Retreatment rates were 34% at 1 year and 42% at 5 years. Some reconstructive centers instead offer reconstruction after a single failed attempt[3][10][11]
Obliterative stenosisReconstruction or diversionEAU strongly discourages endoluminal treatment[2]
Radiation-induced stenosisEarly referral for reconstruction planningSee Radiation-Induced Stenosis
PFUIDelayed perineal anastomotic urethroplastySee PFUI
Devastated outletDiversion with or without cystectomy, or long-term suprapubic drainageEAU weak recommendation[2]

Endoscopic Treatment​

Outcomes. A meta-analysis of 40 studies (1,452 patients) of endoscopic VUAS treatment found 72.8% overall success, falling to 62.9% after correction for publication bias. Radiotherapy was associated with lower success on meta-regression.[12] Holmium laser incision outperformed the other modalities in one 142-patient series.[3] Techniques are described on Transurethral Incision of BNC, Transurethral Bladder Neck Resection and DVIU and Urethral Dilation.

Patency versus continence. A deeper incision opens the ring more reliably but threatens continence, especially at the anastomosis:

  • In a 103-patient multi-institutional VUAS series, new incontinence occurred after 31% of incisions versus 12% of resections.[13]
  • After deep lateral incision through the bladder-neck fibers into perivesical fat, 97.7% of 43 men were patent after up to three incisions. However, 88.1% used at least one pad daily and 16.7% later received an AUS.[14]

Counsel before the first incision.

Adjuncts and newer endoscopic options:

OptionEvidenceStatus
Mitomycin C55-patient TURNS series: 58% success after one treatment, 75% overall; 7% serious adverse events[15]EAU restricts use to clinical trials.[16] See Antimitotics & Antifibrotics
Intralesional corticosteroidRecalcitrant VUAS: incision with triamcinolone succeeded in 15 of 18 (83%; 78% radiated; 28% complications). Plasma-button incision with triamcinolone gave 85% patency in 20 patients, but every completely obliterated stenosis recurred[17][18]Small retrospective series. See Intralesional Corticosteroids
Transurethral incision with transverse mucosal realignment (TUITMR)First series: 19 BNC/VUAS patients, 89% success after one procedure. Later registry: 92 men with BNC after benign prostate surgery, 93.5% anatomic success, 83.7% free of reintervention after one procedure, no new incontinence at median 15.9 months[19][20]Single-group data from the originating team. Long stenoses with radionecrosis may lack the mucosal laxity needed.[21] See TUITMR
Drug-coated balloonRetrospective 141-patient VUAS/BNC comparison: better recurrence-free survival than standard endoscopy (HR 0.40)[22]. In radiation-induced posterior stenosis, a four-institution retrospective series (Optilume, 37 men with at least 90 days of follow-up) reported 81% free from repeat intervention and no complication above Clavien IIIb; follow-up was short[56]No guideline recommendation for posterior disease. See Drug-Coated Balloon Therapy
Permanent urethral stentLow patency and high incontinenceEAU discourages; SIU allows[2]

Reconstruction by Entity​

  • BNC. Y-V or T-plasty and robotic reconstruction. See the BNC treatment atlas.
  • VUAS. In the TURNS robotic series, 24 of 32 men (75%) were patent at median 12 months, and 11 of 13 initially continent men stayed continent.[23] Open series report durable patency, but most men are incontinent afterward, often because they were incontinent beforehand.[24][25] A 28-patient comparison found similar patency after open perineal and robotic repair (77.8% versus 80%) but more new incontinence after perineal repair (100% versus 16.6%), with small numbers.[26] Radiation raises complications and reintervention. See Vesicourethral Anastomotic Stenosis, including its radiation section and one center's treatment algorithm.
  • Membranous stenosis after endoscopic prostate surgery. A non-transecting dorsal onlay buccal graft avoids circumferential sphincter dissection. In a 107-patient multi-institutional series, 10 men (9.35%) had recurrence at mean 59.3 months, with one case of new stress incontinence. Prior radiation predicted recurrence (OR 8.3).[27] Barbagli's sphincter-preserving ventral onlay reported 11 recurrences and 3 cases of incontinence among 69 men.[28] See Dorsal Onlay BMG for BNC / VUAS.
  • PFUI. Delayed perineal anastomotic urethroplasty with progressive maneuvers; abdominoperineal repair when needed. See PFUI and Abdominoperineal (Transpubic) Urethroplasty.
  • Radiation-induced bulbomembranous stenosis. See Choosing a reconstruction after radiation below.
  • Devastated outlet. See Devastated outlet, fistula and diversion, Urinary Diversion Principles and Cancer Survivorship.

Radiation-Induced Stenosis​

Radiation-induced posterior urethral stenosis is fibrotic narrowing proximal to the corpus spongiosum after pelvic radiotherapy, almost always for prostate cancer. It most often involves the bulbomembranous urethra, where the membranous urethra and external sphincter lie just below the prostatic apex in the high-dose field.[29][30] This section focuses on bulbomembranous disease. Anastomotic stenosis after prostatectomy and radiation is covered under VUAS After Radiation. Stenosis of a radiated bladder neck or prostatic urethra is covered under BNC in the Radiated Prostate.

It is the most difficult form of posterior stenosis. The scar lies in poorly vascularized tissue beside the continence mechanism, endoscopic treatment is generally less durable, and every definitive repair risks continence or erectile function in exchange for patency.[31][12][29] For the tissue biology of irradiated fields, see Radiation & Tissue Effects.

Why radiated scar behaves differently​

Hughes and colleagues compared 19 post-radiation membranous stenosis specimens with 51 nonradiated specimens. Radiated scar had denser, more organized collagen, more hyalinized fibrosis, fat entrapment, spindle-cell change and vacuolar degeneration, with significantly reduced vascularity.[31] The underlying mechanism is oxidative injury to small-vessel endothelium, which causes ischemia and extracellular fibrosis. Breakdown of the urothelium can let urine leak into the tissue and drive further fibrosis, and irradiated fibroblasts deposit excess collagen.[21]

This has three practical consequences:

  • An incision heals by secondary intention in ischemic scar.
  • A free graft depends on a recipient bed that may be poorly perfused.
  • Injury continues to evolve for years after treatment.

In a 733-patient cohort with at least 100 months of follow-up after urethroplasty, radiation etiology was independently associated with long-term recurrence (HR 4.25, 95% CI 1.65–10.9).[32]

Incidence and timing after radiation​

SourcePopulationFinding
Awad 2018 meta-analysis46 studies; 16,129 men treated with RT for prostate cancerPooled stricture prevalence was 2.2% at median 4-year follow-up: 1.5% after EBRT, 1.9% after brachytherapy and 4.9% after both. Median time to stricture was 2.2 years. Longer follow-up was associated with more strictures.[33]
ASCENDE-RTRandomized trial of low-dose-rate brachytherapy boost versus dose-escalated EBRT boostFive-year cumulative incidence of grade 3 genitourinary events was 18.4% versus 5.2%. The five-year prevalence was lower (8.6% versus 2.2%). This is a composite toxicity endpoint, not a stricture rate.[34]
Sullivan 2009474 men treated with high-dose-rate brachytherapy, 90% as a boost to EBRT38 strictures (8%) at median 41 months; 6-year actuarial risk 12%; 92.1% bulbomembranous; median time to diagnosis 22 months. Prior TURP (HR 2.81), hypertension (HR 2.83) and a higher dose per fraction predicted stricture.[35]
Merrick 20061,186 men treated with permanent brachytherapy29 strictures, all bulbomembranous; 9-year actuarial risk 3.6%; median onset 2.4 years. Higher radiation dose to the bulbomembranous urethra and supplemental EBRT predicted stricture.[36]
Calvo & Rourke 2026Alberta registry; 47,387 men; median follow-up 79 monthsFifteen-year incidence of urethral complications (stenosis, fistula or a urethral procedure more than 30 days after treatment): EBRT plus cryotherapy 42%, EBRT plus brachytherapy 26%, prostatectomy plus EBRT 22%, prostatectomy alone 9% and observation or medical therapy 8%. Complications after prostatectomy plateaued by 10 years; radiation-containing treatments continued to accumulate them.[37]

The dose relationship helps explain why the bulbomembranous urethra, just below the prostatic apex, is the usual site. Presentation years after treatment is common. In Hofer's multi-institutional series, the mean interval from radiotherapy to EPA was 6.4 years (range 1–20).[30] These are population and trial estimates, not an individual risk for a contemporary radiation plan.

Evaluation after radiation​

History. In addition to the general evaluation above, record:

  • Storage symptoms, pain and hematuria from radiation cystitis.
  • Continence before any treatment and now, including pad use and previous AUS.
  • Erectile function.
  • Previous dilations, incisions, TURP and urethroplasty.
  • Radiation modality, cancer status, PSA and androgen deprivation.

Fistula warning signs: pneumaturia, fecaluria or urine per rectum suggest a rectourethral fistula. Pubic or groin pain, pain on walking or osteomyelitis suggest a urethropubic (urosymphyseal) fistula. Either changes the operation, and may change the goal.

Predicting continence. After bulbomembranous reconstruction, continence depends on the bladder neck and whatever external sphincter survives the stenosis and the repair. Assess the bladder neck at rest on cystogram or antegrade cystoscopy, and document baseline continence carefully. Chung selected only men with an intact bladder neck on imaging. Even so, 33% (12/36) developed new stress incontinence after EPA, and 9 of those 12 had stenosis extending into the prostatic urethra.[38] An open bladder neck, or disease extending into the prostatic urethra, should prompt explicit counseling about incontinence, a later AUS, or accepting long-term drainage.

Bladder function. A patent urethra does not help a small, painful or poorly compliant bladder. Ivan and colleagues consider men poor candidates for reconstruction that keeps the native bladder when they have:[21]

  • poor bladder compliance or capacity;
  • significant pelvic pain or dysuria, which should prompt a search for fistula;
  • refractory radiation cystitis needing repeated intervention.

Obtain urodynamics when storage symptoms dominate or when reconstruction versus diversion is undecided. Suprapubic drainage before urethroplasty allows the urethra to recover from recent catheterization or dilation.[4]

Endoscopic and conservative management after radiation​

  • Non-obliterative stenosis. Dilation or incision is reasonable as a first step. SIU and EAU guidance allows repeat endoluminal treatment to stabilize patency.[2]
  • Incision position. EAU strongly advises against deep incisions at 6 o'clock, which risk rectal injury and a rectourethral fistula. It also advises against deep incisions at 12 o'clock, which risk a urosymphyseal fistula.[2]
  • Obliterative stenosis. EAU strongly discourages endoluminal treatment and favors reconstruction or diversion.[2] Do not core through an obliterated radiated segment without direct control of both lumens.

Endoscopic outcomes for radiated bulbomembranous stenosis:

SeriesPopulationOutcome
Merrick 200629 bulbomembranous strictures after permanent brachytherapyAll but 3 treated successfully with dilation or urethrotomy[36]
Sullivan 200935 bulbomembranous strictures after high-dose-rate brachytherapy, first treated by dilation (15) or urethrotomy (20)17 (49%) needed second-line treatment, 3 third-line and 1 urethroplasty[35]
Farrell 201718 recurrent radiation-induced bulbar or bulbomembranous strictures; DVIU with mitomycin C and 1 month of self-catheterization66.7% needed no further surgery after one procedure; 14 of 16 (87.5%) after a second[39]

For anastomotic stenosis after prostatectomy and radiation, see VUAS After Radiation. Adjuncts are summarized under Endoscopic Treatment.

Maintenance and palliation. Intermittent self-dilation or catheterization and long-term suprapubic drainage are legitimate choices. EAU cites a series of radiation-induced bulbomembranous strictures managed with a suprapubic tube. Only 51% went on to urethroplasty (mean follow-up 25 months), and 27% of those who kept the catheter had catheter-related complications.[16]

When to stop repeating endoscopy. Refer for reconstruction in any of these situations:

  • Recurrence after one or two technically adequate endoscopic treatments.
  • Obliteration.
  • Fistula or osteomyelitis.
  • When a future AUS depends on preserving the urethra.

Choosing a reconstruction after radiation​

For radiation-induced bulbomembranous strictures refractory to endoscopic treatment, EAU 2026 allows EPA or augmentation urethroplasty for short strictures below 2.5 cm, according to anatomy and expertise. It recommends augmentation for longer strictures and counseling about new incontinence and erectile dysfunction.[16] A meta-analysis of eight retrospective studies (256 patients, 83% bulbomembranous) found pooled stenosis resolution of 80% (95% CI 74–86%). It found no significant association with technique or radiation modality. Pooled new stress incontinence was 19% (95% CI 10–31%).[29]

FindingsFavored approachBasis
Short (about 2–2.5 cm or less), obliterative or near-obliterative bulbomembranous segment; healthy proximal urethra reachable; competent bladder neckEPALowest long-term recurrence in comparative data[5]
Longer (more than 2.5 cm) or non-obliterative stenosis with a usable dorsal urethral plateDorsal onlay buccal mucosa graft (BMG)Guideline preference for augmentation of longer segments; avoids circumferential excision under tension[16][40]
Pre-existing incontinence, or an AUS is likely to be neededNon-transecting repair (dorsal onlay BMG or non-transecting anastomotic technique)Transecting urethroplasty is associated with more AUS erosion and explantation[6][41]
Long segment, poor graft bed or previous failed repairVentral BMG with a gracilis muscle flap16 of 20 (80%) successful in a high-risk series[42]
Radionecrosis, cavitation, dystrophic calcification, fistula, pubic osteomyelitis, a small or painful bladder, or repeated failureDiversion or long-term suprapubic drainage; subtotal (salvage) prostatectomy or fistula repair where feasiblePatency alone will not restore function[43][16][21]

Robotic transabdominal repair stays above the external sphincter and suits anastomotic disease more than bulbomembranous disease. Its results after radiation are less favorable than in nonradiated men; see VUAS After Radiation.

Excision and primary anastomosis after radiation​

The general operation is described on Excision and Primary Anastomosis. The radiation-specific points are:

  1. Exposure. Use lithotomy through a perineal incision (see incisions and approaches), and keep lithotomy time as short as practical. Mobilize the bulbar urethra to the bulbomembranous junction.
  2. Find the proximal lumen. Pass a sound, Gelman visualizing sound or flexible cystoscope antegrade through the suprapubic tract to locate the proximal urethra.
  3. Excise all radiated scar back to healthy, bleeding mucosa. The healthy proximal margin often lies in the prostatic urethra. In Chung's series, dissection extended into the prostatic urethra in 67% of radiation cases.[38]
  4. Build a spatulated, tension-free, mucosa-to-mucosa anastomosis. This follows the core principles of urethral reconstruction.
  5. Gain length only as needed. Use the progressive perineal maneuvers (crural separation, inferior pubectomy and, rarely, supracrural rerouting) described for PFUI.
  6. Consider tissue interposition selectively. In the 137-patient TURNS series, gracilis use was not associated with recurrence.[44]
  7. Drain and confirm. Leave urethral and suprapubic catheters, and image before removing the urethral catheter. Schedule early surveillance cystoscopy; reported protocols use cystoscopy at 4 months, or at 6 and 12 months.[45][46]

Adjunct maneuvers. In the TURNS EPA series, surgeons used corporal splitting in 71.5% of cases, partial prostatectomy in 37.2%, partial pubectomy in 12.4% and a gracilis flap in 23.4%. Ivan and colleagues' summary of the full report gives new stress incontinence of 32.1%.[44][21]

Vessel-sparing and non-transecting variants. Vessel-sparing EPA and non-transecting anastomotic repair preserve bulbar blood supply in nonradiated tissue. No radiation-specific comparison shows a continence advantage, and radiation may already have compromised the bulbar arteries. The AUS literature nevertheless favors non-transecting repair when a sphincter is anticipated.[6]

EPA outcomes after radiation:

SeriesPatientsPatencyContinence and other outcomesFollow-up
Meeks 2011, 3 centers30 (24 EPA, 4 flap, 2 BMG)73%Persistent incontinence 40%, transient 10%; 13% received an AUS; ED unchanged (47% to 50%)[47]Mean 21 months
Hofer 2014, 3 centers66 EPA (of 72 treated)69.7%New incontinence in 12 (18.5%), associated with length over 2 cm and treating center[30]Mean 3.5 years
Rourke 201635 (23 EPA, 7 BMG, 5 flap)85.7% (whole group)Adverse change in continence 25.7% (13.3% without prior TURP); adverse erectile change 30.4%, all after EPA[46]Mean 50.5 months
Chung 201836 successful EPA, intact bladder neckNot the endpointNew SUI 33%; 9 of 12 had prostatic-urethral involvement; 2 received an AUS[38]Mean 18 months
Keith 2020, single center116 EPARecurrence 19.0% overall; 36.6% (15/41) among men followed for at least 1 yearPostoperative complications predicted recurrence[48]Mean 30.7 months in the at-least-1-year group
Voelzke 2021, 10 centers (TURNS)137 EPA; mean length 2.3 cm86.9%Later AUS in 30 (21.9%): 25 transcorporal cuffs, 5 erosions[44]Mean 32.3 months
Barnard 202323 EPA with PROMs91.3%Satisfaction 91.3% despite sexual side effects[45]Mean 73.1 months
Rourke & Gelman 2026, 2 centers163 EPA10-year recurrence 6.8%New incontinence 18%; new ED 8.2%[5]Median 97 months without recurrence

Predictors of EPA failure. In the TURNS series, older age (HR 1.09) and longer stenosis (HR 2.62) independently predicted recurrence; combined-modality radiotherapy was significant only on univariate analysis.[44] Keith's rising recurrence with longer follow-up shows why short-term patency overstates durability.[48] Several series share centers and possibly patients, so do not add them together.

Buccal mucosa graft substitution after radiation​

Dorsal onlay (non-transecting). A dorsal onlay opens the stenosis along its dorsal surface and augments it with oral mucosa, avoiding circumferential transection and extensive mobilization of the membranous urethra. Kaldany, Cedars and Nikolavsky describe their technique as follows:[49]

  1. Moderate lithotomy with slight Trendelenburg; midline perineal incision.
  2. Unilateral bulbospongiosus dissection, usually on the left, to limit disturbance of neurovascular supply and muscular support.
  3. Dorsal longitudinal urethrotomy over a bougie à boule, with excision of a dorsal wedge of fibrosis between 11 and 1 o'clock. Dorsal dissection is kept limited to protect the rhabdosphincter.
  4. The buccal graft is fixed distally with a temporary stay. Proximal apical sutures are passed outside-in with a bent J-hook ("ski") needle, or with the RD180 device for deep defects. The graft is then parachuted into place.
  5. The graft is quilted with running sutures; alternatives include the RD180, fibrin sealant or barbed suture. A lighted urethral speculum aids exposure.
  6. A 16 Fr silicone catheter remains for 3 weeks, with retrograde urethrography before removal. Cystoscopy is done at 1 year.

See Dorsal Onlay BMG for BNC / VUAS, Dorsal Onlay Oral Mucosal Graft Urethroplasty and Buccal Mucosa Graft for graft harvest and other technical variants. The Nikolavsky video below shows this operation.

Ventral onlay and graft-plus-flap repair. Ventral onlay needs less dorsal dissection. In radiated series, however, recurrence was 29–33%, and new or persistent incontinence was common (see table below).[50][51] Barbagli's sphincter-preserving ventral technique reported incontinence in 3 of 69 men, but its population had post-TURP stenosis without radiation.[28] For long strictures in a poor bed, a ventral BMG placed on a vascularized gracilis flap is an option for the highest-risk cases.[42]

BMG outcomes after radiation:

SeriesPatientsPatencyContinence and other outcomesFollow-up
Policastro 2021, 10 centers79 dorsal onlay; median length 3.0 cmRecurrence 17.7%New SUI in 3 of 37 previously continent men (8.1%); 28 of 29 incontinent men stayed incontinent[40]Median 21 months
Sterling 2024, 8 centers45 dorsal onlay after prostatectomy plus RT7 recurrencesNo new SUI reported; 28 were incontinent before and after; 4 of 6 men with a preoperative suprapubic tube were continent after repair[52]Median 21 months without recurrence
Kaldany 2025, single center18 dorsal onlay for VUAS after prostatectomy plus RT89%No new incontinence[49]Median 39.9 months
Ahyai 201538 ventral onlay; median length 3.0 cm71.1%New incontinence 10.5%[50]Median 26.5 months
Vetterlein 202047 ventral onlayRecurrence 33%53% reported daily leakage; 26% later had an AUS; mean IIEF-EF 4.4[51]Median 44 months
Palmer 201520 ventral BMG with gracilis; mean length 8.2 cm; 45% radiation80%25% needed an AUS[42]Mean 40 months
Rourke & Gelman 2026, 2 centers49 BMG onlay10-year recurrence 20%New incontinence 18%; new ED 15%[5]Median 97 months without recurrence

The Policastro, Sterling and Kaldany cohorts include overlapping institutions.

EPA versus BMG​

Rourke and Gelman 2026 is the largest comparison. It reviewed 212 men with radiation-induced bulbomembranous stenosis at two centers (2001–2024): 163 underwent anastomotic urethroplasty and 49 buccal onlay. Median stenosis length was 2.0 cm, and median follow-up in men without recurrence was 97 months. The radiation was brachytherapy in 46%, EBRT in 45% and combined in 9%. Recurrence was defined as a stricture narrower than 16 Fr on cystoscopy.[5]

  • BMG was independently associated with recurrence (HR 3.43, 95% CI 1.03–11.47; P = .046).
  • Estimated recurrence at 1, 2 and 10 years was 17%, 18% and 20% after BMG, versus 3.3%, 5.0% and 6.8% after EPA.
  • The groups did not differ in complications (10% versus 4.1%), satisfaction (90% versus 88%), new erectile dysfunction (15% versus 8.2%) or new incontinence (18% versus 18%).

The authors concluded that anastomotic repair is preferable when technically feasible. The study was retrospective, surgeons chose the technique, and the confidence interval is wide. It shows an association, not proof that EPA would have succeeded in the men who received a graft.

Why the continence data appear to conflict. Dorsal onlay series report very low new-incontinence rates, yet the head-to-head comparison found no difference. Three points reconcile this:

  1. Denominators. Many dorsal onlay patients were already incontinent: 28 of 45 in Sterling and 29 of 79 in Policastro. Only continent men can develop new incontinence. Policastro's 8.1% applies to its 37 continent men.[52][40]
  2. Anatomy. EPA-associated incontinence concentrates in stenoses extending into the prostatic urethra and in those longer than 2 cm.[38][30] These are the stenoses most often grafted.
  3. Direct comparison. When the same two centers compared techniques, new incontinence was identical at 18%.[5]

Practical synthesis. For a short, obliterative bulbomembranous stenosis with a competent bladder neck, EPA gives the most durable patency and is preferred when technically feasible. For longer or non-obliterative disease, pre-existing incontinence, or when preserving the urethra for a future AUS is the priority, a non-transecting dorsal onlay graft is reasonable. The trade-off is a higher long-term recurrence risk.[5][16][6]

Devastated outlet, fistula and diversion​

A devastated outlet is recalcitrant stenosis with loss of useful voiding function, often with fistula, necrosis, pubic-bone involvement or an end-stage bladder. It calls for a decision between reconstruction and planned diversion, not another endoscopic attempt.

  • Diversion series. Faris reviewed 30 men diverted after prostate RT. Indications were fistula (37%), end-stage bladder (20%), devastated outlet (27%), or end-stage bladder plus devastated outlet (17%). Patients had undergone a mean of 4.4 salvage procedures first. Options included cystectomy with conduit, conduit alone and a long-term indwelling suprapubic tube. Every patient with a rectourethral fistula had received brachytherapy seeds.[43]
  • Guidance. EAU suggests diversion for an incapacitated bladder or disabling local symptoms, and cystectomy for intractable bladder pain, spasms or hematuria (weak recommendations).[2] See Urinary Diversion Principles and Cancer Survivorship.
  • Orthotopic salvage. Patil described salvage cystectomy, ileal neobladder and urethral pull-through with staged AUS in 8 highly selected patients, 6 after radiation. All were socially continent at median 58 months, after a median of 2 AUS revisions.[53]
  • Rectourethral fistula. In a 201-patient multi-institutional series, repair succeeded in 87% after energy ablation versus 99% after prostatectomy alone. Concomitant BNC or stricture was present in 26% versus 14%.[54] See Rectourethral Fistula and Transperineal Approach to RUF.

Continence, AUS and Follow-Up​

Sequence. Resolve the stenosis, confirm stable patency cystoscopically, then treat stress incontinence. EAU advises deferring incontinence surgery for at least 6 months after a redo vesicourethral anastomosis.[2] Implanting a sphincter over an unstable urethra risks erosion and makes recurrent stenosis harder to treat. See Artificial Urinary Sphincter (Procedure) and Stress Urinary Incontinence (Male).

AUS risk after radiation and urethroplasty:

StudyDesignFinding
McGeady 201486 AUS at one institutionCompared with an uncompromised urethra, failure risk increased with prior radiation (HR 4.78), prior urethroplasty (HR 8.61) and prior AUS (HR 8.14). A 3.5 cm cuff carried higher failure risk (HR 8.62); transcorporal placement did not (HR 1.21). Confidence intervals were wide.[7]
Davis 2026178 AUS after urethroplasty; 15 institutionsComplications requiring explantation occurred in 56.2% after transecting urethroplasty versus 23.5% after non-transecting urethroplasty.[6]
Deameh 2026Meta-analysis; 4 studies, 533 patientsPrior urethroplasty was associated with explantation (RR 2.05). Transecting repair was associated with erosion (RR 2.34) and explantation (RR 2.38) compared with non-transecting repair. All included studies were observational.[41]
Voelzke 2021AUS after EPA for radiation stenosis30 of 137 men received an AUS; 25 needed a transcorporal cuff and 5 eroded.[44]

When an AUS is likely, choose a repair that keeps the urethra intact where anatomy allows. Consider a transcorporal cuff in a compromised urethra, and counsel patients about the higher erosion and explantation risk.

Follow-up.

  • Surveillance cystoscopy. In a 304-patient TURNS urethroplasty cohort, a lumen narrower than 17 Fr at the first postoperative urethroscopy (median 3.7 months) led to secondary intervention in 64%, versus 15% with a normal lumen.[8] In a prospective endoscopic follow-up series, 26 of 27 recurrences appeared within the first year, and 7 of the 11 recurrences with flow data had a peak flow above 15 mL/s. Flow rate alone misses recurrence.[55]
  • Longer review after radiation. Radiation-related urethral complications keep accumulating, and radiation predicts late recurrence. Follow these patients, and those with long stenoses or prior failed repair, longer than the one-year minimum used after routine urethroplasty.[37][32]
  • Beyond patency. Reassess continence, erectile function, storage symptoms, hematuria and fistula symptoms. Coordinate cancer surveillance with the treating team.

Evidence Limitations​

  • The literature is almost entirely retrospective, from high-volume referral centers, with mixed entities and overlapping cohorts.
  • Success definitions differ: cystoscopic caliber of 16–17 Fr, need for further instrumentation, or voiding without a catheter.
  • No randomized trial compares dilation, incision and resection, or EPA and graft repair. Technique was chosen by the surgeon based on anatomy. The best number of endoscopic attempts before escalation is undefined.
  • Data on mitomycin C, drug-coated balloons, TUITMR and robotic reconstruction are early or single-group.
  • New-incontinence rates depend on whether men who were already incontinent are counted in the denominator.
  • Few studies separate EBRT, brachytherapy, combined treatment and radiation after prostatectomy.

See Also​

Videos​

Urethroplasty for Radiated VUAS With Dorsal BMG
Dmitriy Nikolavsky · semi-live surgery and discussion
Repair of Post-Radiation Membranous Stricture Using EPA and Gracilis Wrap
Sean Elliott MD

References​

1. Latini JM, McAninch JW, Brandes SB, et al. SIU/ICUD Consultation On Urethral Strictures: Epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuries. Urology. 2014;83(3 Suppl):S1-7. doi:10.1016/j.urology.2013.09.009

2. Abbasi B, Shaw NM, Lui JL, et al. Posterior urethral stenosis: a comparative review of the guidelines. World J Urol. 2022;40(11):2591-2600. doi:10.1007/s00345-022-04131-y

3. LaBossiere JR, Cheung D, Rourke K. Endoscopic Treatment of Vesicourethral Stenosis after Radical Prostatectomy: Outcomes and Predictors of Success. J Urol. 2016;195(5):1495-1500. doi:10.1016/j.juro.2015.12.073

4. Wessells H, Morey A, Souter L, et al. Urethral Stricture Disease Guideline Amendment (2023). J Urol. 2023;210(1):64-71. doi:10.1097/JU.0000000000003482

5. Rourke K, Gelman J. Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared with Buccal Mucosa Graft Onlay After Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis. J Urol. Published online August 26, 2026. doi:10.1097/JU.0000000000005279

6. Davis MF, Nikolavsky D, Cavalcanti AG, et al. Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery After Urethroplasty. J Urol. 2026;215(2):203-212. doi:10.1097/JU.0000000000004794

7. McGeady JB, McAninch JW, Truesdale MD, et al. Artificial urinary sphincter placement in compromised urethras and survival: a comparison of virgin, radiated and reoperative cases. J Urol. 2014;192(6):1756-61. doi:10.1016/j.juro.2014.06.088

8. Amend GM, Nabavizadeh B, Hakam N, et al. Urethroscopic Findings following Urethroplasty Predict the Need for Secondary Intervention in the Long Term: A Multi-Institutional Study from Trauma and Urologic Reconstructive Network of Surgeons. J Urol. 2022;207(4):857-865. doi:10.1097/JU.0000000000002353

9. Castellani D, Wroclawski ML, Pirola GM, et al. Bladder neck stenosis after transurethral prostate surgery: a systematic review and meta-analysis. World J Urol. 2021;39(11):4073-4083. doi:10.1007/s00345-021-03718-1

10. Britton CJ, Sharma V, Fadel AE, et al. Vesicourethral Anastomotic Stenosis Following Radical Prostatectomy: Risk Factors, Natural History, and Treatment Outcomes. J Urol. 2023;210(2):312-322. doi:10.1097/JU.0000000000003488

11. Naser-Tavakolian A, Lee Z. A review of management options for vesicourethral anastomotic stenosis and the emergence of robotic reconstruction. Transl Androl Urol. 2025;14(8):2405-2418. doi:10.21037/tau-24-503

12. Delchet O, Nourredine M, González Serrano A, et al. Post-prostatectomy anastomotic stenosis: systematic review and meta-analysis of endoscopic treatment. BJU Int. 2024;133(3):237-245. doi:10.1111/bju.16141

13. Pfalzgraf D, Worst T, Kranz J, et al. Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy. World J Urol. 2021;39(1):89-95. doi:10.1007/s00345-020-03157-4

14. Shinchi M, Horiguchi A, Ojima K, et al. Deep lateral transurethral incision for vesicourethral anastomotic stenosis after radical prostatectomy. Int J Urol. 2021;28(11):1120-1126. doi:10.1111/iju.14650

15. Redshaw JD, Broghammer JA, Smith TG 3rd, et al. Intralesional injection of mitomycin C at transurethral incision of bladder neck contracture may offer limited benefit: TURNS Study Group. J Urol. 2015;193(2):587-92. doi:10.1016/j.juro.2014.08.104

16. European Association of Urology. EAU Guidelines on Urethral Strictures: Disease Management in Males. 2026. Radiation-induced posterior strictures, adjunctive intralesional agents, suprapubic drainage and urinary diversion. Guideline

17. Neu S, Vigil H, Locke JA, et al. Triamcinolone acetonide injections for the treatment of recalcitrant post-radical prostatectomy vesicourethral anastomotic stenosis: A retrospective look at efficacy and safety. Can Urol Assoc J. 2021;15(3):E175-E179. doi:10.5489/cuaj.6644

18. Shaw NM, Marhamati S, Friedman A, et al. Recurrent vesicourethral anastomotic stenosis following treatment for prostate cancer: an effective endoscopic treatment using bipolar plasma button and triamcinolone. Int Urol Nephrol. 2022;54(5):1001-1008. doi:10.1007/s11255-022-03153-0

19. Abramowitz DJ, Balzano FL, Ruel NH, et al. Transurethral Incision with Transverse Mucosal Realignment for the Management of Bladder Neck Contracture and Vesicourethral Anastomotic Stenosis. Urology. 2021;152:102-108. doi:10.1016/j.urology.2021.02.035

20. Curtis J, Schrup S, Moring N, et al. Transurethral Incision With Transverse Mucosal Realignment for the Treatment of Bladder Neck Contractures After Benign Prostate Surgery; Mid-term Outcomes. Urology. Published online July 16, 2026. doi:10.1016/j.urology.2026.07.018

21. Ivan SJ, Lee M, Simhan J. Contemporary management of radiation-associated posterior urethral stenosis: a narrative review. Transl Androl Urol. 2025;14(10):3377-3386. doi:10.21037/tau-2025-183

22. Berg EK, Mehmedovic S, Askari D, et al. Efficacy of Drug-coated Balloon Dilation Versus Endoscopic Standard Treatment in Posterior Urethral Stenosis: A Real-world Comparative Study. Urology. 2025;206:164-170. doi:10.1016/j.urology.2025.07.034

23. Shakir NA, Alsikafi NF, Buesser JF, et al. Durable Treatment of Refractory Vesicourethral Anastomotic Stenosis via Robotic-assisted Reconstruction: A Trauma and Urologic Reconstructive Network of Surgeons Study. Eur Urol. 2022;81(2):176-183. doi:10.1016/j.eururo.2021.08.013

24. Reiss CP, Pfalzgraf D, Kluth LA, et al. Transperineal reanastomosis for the treatment for highly recurrent anastomotic strictures as a last option before urinary diversion. World J Urol. 2014;32(5):1185-90. doi:10.1007/s00345-013-1180-6

25. Nikolavsky D, Blakely SA, Hadley DA, et al. Open reconstruction of recurrent vesicourethral anastomotic stricture after radical prostatectomy. Int Urol Nephrol. 2014;46(11):2147-52. doi:10.1007/s11255-014-0816-9

26. Savun M, Çolakoğlu Y, Özdemir H, et al. Comparison of open perineal and robot-assisted reconstruction in vesicourethral anastomotic stenosis. World J Urol. 2025;43(1):413. doi:10.1007/s00345-025-05808-w

27. Angulo JC, Dorado JF, Policastro CG, et al. Multi-Institutional Study of Dorsal Onlay Urethroplasty of the Membranous Urethra after Endoscopic Prostate Procedures: Operative Results, Continence, Erectile Function and Patient Reported Outcomes. J Clin Med. 2021;10(17):3969. doi:10.3390/jcm10173969

28. Barbagli G, Kulkarni SB, Joshi PM, et al. Repair of sphincter urethral strictures preserving urinary continence: surgical technique and outcomes. World J Urol. 2019;37(11):2473-2479. doi:10.1007/s00345-019-02686-x

29. Sapienza LG, Ning MS, Carvalho EF, et al. Efficacy and Incontinence Rates After Urethroplasty for Radiation-induced Urethral Stenosis: A Systematic Review and Meta-analysis. Urology. 2021;152:109-116. doi:10.1016/j.urology.2021.02.014

30. Hofer MD, Zhao LC, Morey AF, et al. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease. J Urol. 2014;191(5):1307-12. doi:10.1016/j.juro.2013.10.147

31. Hughes M, Caza T, Li G, et al. Histologic characterization of the post-radiation urethral stenosis in men treated for prostate cancer. World J Urol. 2020;38(9):2269-2277. doi:10.1007/s00345-019-03031-y

32. Calvo CI, Fender K, Hoy N, et al. Affirming Long-Term Outcomes After Contemporary Urethroplasty: The Adverse Impact of Increasing Stricture Length, Lichen Sclerosus, Radiation, and Infectious Strictures. J Urol. 2024;211(3):455-464. doi:10.1097/JU.0000000000003826

33. Awad MA, Gaither TW, Osterberg EC, et al. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2018;21(2):168-174. doi:10.1038/s41391-017-0028-3

34. Rodda S, Tyldesley S, Morris WJ, et al. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017;98(2):286-295. doi:10.1016/j.ijrobp.2017.01.008

35. Sullivan L, Williams SG, Tai KH, et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91(2):232-6. doi:10.1016/j.radonc.2008.11.013

36. Merrick GS, Butler WM, Wallner KE, et al. Risk factors for the development of prostate brachytherapy related urethral strictures. J Urol. 2006;175(4):1376-80; discussion 1381. doi:10.1016/S0022-5347(05)00681-6

37. Calvo CI, Rourke KF. Delineating the Long-Term Incidence of Urethral Complications After Prostate Cancer Treatment: A Population-Based Analysis. J Urol. Published online August 7, 2026. doi:10.1097/JU.0000000000005222

38. Chung PH, Esposito P, Wessells H, et al. Incidence of Stress Urinary Incontinence After Posterior Urethroplasty for Radiation-induced Urethral Strictures. Urology. 2018;114:188-192. doi:10.1016/j.urology.2017.11.024

39. Farrell MR, Lawrenz CW, Levine LA. Internal Urethrotomy With Intralesional Mitomycin C: An Effective Option for Endoscopic Management of Recurrent Bulbar and Bulbomembranous Urethral Strictures. Urology. 2017;110:223-227. doi:10.1016/j.urology.2017.07.017

40. Policastro CG, Simhan J, Martins FE, et al. A multi-institutional critical assessment of dorsal onlay urethroplasty for post-radiation urethral stenosis. World J Urol. 2021;39(7):2669-2675. doi:10.1007/s00345-020-03446-y

41. Deameh MG, Mohamed H, Abdelshafi A, et al. Association of Prior Urethroplasty and Technique With Outcomes After Artificial Urinary Sphincter Implantation: A Systematic Review and Meta-analysis. Urology. 2026;214:135-142. doi:10.1016/j.urology.2026.05.024

42. Palmer DA, Buckley JC, Zinman LN, et al. Urethroplasty for high risk, long segment urethral strictures with ventral buccal mucosa graft and gracilis muscle flap. J Urol. 2015;193(3):902-5. doi:10.1016/j.juro.2014.09.093

43. Faris SF, Milam DF, Dmochowski RR, et al. Urinary diversions after radiation for prostate cancer: indications and treatment. Urology. 2014;84(3):702-6. doi:10.1016/j.urology.2014.04.023

44. Voelzke BB, Leddy LS, Myers JB, et al. Multi-institutional Outcomes and Associations After Excision and Primary Anastomosis for Radiotherapy-associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment. Urology. 2021;152:117-122. doi:10.1016/j.urology.2020.11.077

45. Barnard J, Liaw A, Gelman J. Long-term follow-up suggests high satisfaction rates for bulbomembranous radiation-induced urethral stenoses treated with anastomotic urethroplasty. World J Urol. 2023;41(7):1905-1912. doi:10.1007/s00345-023-04429-5

46. Rourke K, Kinnaird A, Zorn J. Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer. World J Urol. 2016;34(3):377-82. doi:10.1007/s00345-015-1608-2

47. Meeks JJ, Brandes SB, Morey AF, et al. Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience. J Urol. 2011;185(5):1761-5. doi:10.1016/j.juro.2010.12.038

48. Keith CG, Davenport MT, Kavoussi M, et al. Long-term outcomes of anastomotic urethroplasty for radiation-induced strictures. World J Urol. 2020;38(12):3055-3060. doi:10.1007/s00345-019-03028-7

49. Kaldany A, Cedars B, Nikolavsky D. Substitution urethroplasty for posterior urethral stenosis. Transl Androl Urol. 2025;14(12):3962-3974. doi:10.21037/tau-2025-566

50. Ahyai SA, Schmid M, Kuhl M, et al. Outcomes of Ventral Onlay Buccal Mucosa Graft Urethroplasty in Patients after Radiotherapy. J Urol. 2015;194(2):441-6. doi:10.1016/j.juro.2015.03.116

51. Vetterlein MW, Kluth LA, Zumstein V, et al. Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM). World J Urol. 2020;38(11):2863-2872. doi:10.1007/s00345-020-03102-5

52. Sterling J, Simhan J, Flynn BJ, et al. Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis. J Urol. 2024;211(4):596-604. doi:10.1097/JU.0000000000003848

53. Patil MB, Hannoun D, Reyblat P, et al. Total bladder and posterior urethral reconstruction: salvage technique for defunctionalized bladder with recalcitrant posterior urethral stenosis. J Urol. 2015;193(5):1649-54. doi:10.1016/j.juro.2014.11.102

54. Harris CR, McAninch JW, Mundy AR, et al. Rectourethral Fistulas Secondary to Prostate Cancer Treatment: Management and Outcomes from a Multi-Institutional Combined Experience. J Urol. 2017;197(1):191-194. doi:10.1016/j.juro.2016.08.080

55. Goonesinghe SK, Hillary CJ, Nicholson TR, et al. Flexible cystourethroscopy in the follow-up of posturethroplasty patients and characterisation of recurrences. Eur Urol. 2015;68(3):523-9. doi:10.1016/j.eururo.2015.04.013

56. Ceballos B, Joshi EG, Graham K, et al. Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience. BMC Urol. 2025;25(1):177. doi:10.1186/s12894-025-01829-0